Wound Botulism Outbreak Among Persons Who Use Black Tar Heroin — San Diego County, California, 2017

Wound Botulism Outbreak Among Persons Who Use Black Tar Heroin — San Diego County, California, 2017–2018

Published:2019-01-04 Issue:5152 Volume:67 Page:1415-1418
ISSN:0149-2195
Container-title:MMWR. Morbidity and Mortality Weekly Report
language:
Short-container-title:MMWR Morb. Mortal. Wkly. Rep.

Author:

Peak Corey M.,Rosen Hilary,Kamali Amanda,Poe Alyssa,Shahkarami Mahtab,Kimura Akiko C.,Jain Seema,McDonald Eric

Publisher

Centers for Disease Control MMWR Office

Subject

Health Information Management,Health, Toxicology and Mutagenesis,General Medicine,Health (social science),Epidemiology

Reference10 articles.

1. County of San Diego Health and Public Health Services, Epidemiology and Immunization Services Branch. Wound botulism associated with black tar heroin. San Diego, CA: County of San Diego Health and Human Services Agency, Epidemiology and Immunization Services Branch; 2017. https://www.sandiegocounty.gov/content/dam/sdc/hhsa/programs/phs/cahan/communications_documents/10-09-2017.pdf

2. County of San Diego Health and Public Health Services, Epidemiology and Immunization Services Branch. Update: wound botulism cases associated with black tar heroin. San Diego, CA: County of San Diego Health and Human Services Agency, Epidemiology and Immunization Services Branch; 2018. https://www.sandiegocounty.gov/content/dam/sdc/hhsa/programs/phs/cahan/communications_documents/04-10-2018.pdf

3. Wound botulism associated with black tar heroin among injecting drug users.;Passaro;JAMA,1998

4. Wound botulism—California, 1995.;CDC;MMWR Morb Mortal Wkly Rep,1995

5. Wound botulism in California, 1951–1998: recent epidemic in heroin injectors.;Werner;Clin Infect Dis,2000

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Botulism;2024-03-19

2. Transformation of a Metal Chelate into a “Catch and Anchor” Inhibitor of Botulinum A Protease;International Journal of Molecular Sciences;2023-02-21

3. Lambert-Eaton Myasthenic Syndrome and Botulism;CONTINUUM: Lifelong Learning in Neurology;2022-12

4. First-in-Human Clinical Trial to Assess the Safety, Tolerability and Pharmacokinetics of Single Doses of NTM-1633, a Novel Mixture of Monoclonal Antibodies against Botulinum Toxin E;Antimicrobial Agents and Chemotherapy;2022-04-19

5. Notes from the Field: Wound Botulism Outbreak Among a Group of Persons Who Inject Drugs — Dallas, Texas, 2020;MMWR. Morbidity and Mortality Weekly Report;2022-04-15